We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS OIG SUBPOENAS J&J UNIT ABOUT OFF-LABEL ACTIVITIES FOR PROCRIT
HHS OIG SUBPOENAS J&J UNIT ABOUT OFF-LABEL ACTIVITIES FOR PROCRIT
October 4, 2004
Johnson & Johnson (J&J) said its subsidiary, Ortho Biotech Products, has received a subpoena from HHS’ Office of the Inspector General (OIG) requesting documents related to the sales and marketing of its Rx anemia treatment Procrit